Global M-Health(mobile health) Market | BIS Research

Global mHealth (Mobile Health) Market: Focus on Ecosystem (mHealth Devices & Services),
Therapeutics, Application/ Solution Type & Regions – Estimation & Forecast through 2015 to 2022
Mobile health (mHealth) is one of the most modernized trends in the healthcare
industry that has shown tremendous progress in the last few years. This trend is
observed due to the flourishing growth of personal health devices, which can be
easily worn or used with a smartphone or tablet. Mobile Health refers to the use of
mobile communications, such as personal digital assistant (PDAs), laptops, and
mobilephonesamongothers,forhealthservicesandinformation.
The mHealth services dominated the market in 2014 and are expected to grow over
$55.63 billion by the end of the forecast period due to the increasing usage of
mHealth solutions by healthcare providers and pharmaceutical companies along
with end users (patients). However, device segment is expected to grow in near
future with a high CAGR of 38.02%, from 2015 to 2022, due to increasing integration
of mHealth devices with smart phones and weareables, and also, increasing
opportunitiesofconnectedhealthsolutionsarepredictedtopromotethegrowthof
thismarketthroughtheforecastperiod.
BIS RESEARCH 2015
www.bisresearch.com ©2015|BIS
Key question answered in the report:
Ÿ Whatarethemajormarketdrivers,challengesandopportunitiesofthemHealthmarketandtheirusecases?
Ÿ Whichfactorswillbedrivingthemarketthroughtheforecastperiod?
Ÿ WhatfactorsarecurrentlychallengingthemHealthindustry?
Ÿ Whataretheusecasesandkeyplatformstodelivertheservicesofeachapplication?
Ÿ Whatarethekeydevelopmentalstrategiesindifferentapplicationsacrossallregions?
Ÿ HowwillthekeymarketplayersleverageonkeydevelopmentssuchasMergersandAcquisitions,Partnerships,andProduct
Launchamongothers?
Ÿ Whichcompliancesandcertificationsarenecessarytomakeaproductacceptable?
Ÿ WhichgeographicalregionwillleadtheglobalmHealthmarketbytheendoftheforecastperiod?
Ÿ WhoarethekeyplayersinthemHealthmarket?
Analysis & Forecast:
Base Year: 2014
8 Year Annual Estimated Forecast
(2015-2022)
Market, By Regions:
North America, Asia Pacific, Europe, Rest
of the World (RoW)
mHealth Market, By Ecosystem: mHealth
Devices (Medical Devices & Health and
Fitness Devices among other devices) &
mHealth Services (Mobile health Apps &
Content Solution, Network and Services/
Mobile operators, Healthcare and
Pharmaceuticals)
mHealth Market, By Therapeutics:
Diabetes, Respiratory, Mental and
Neurological Disorders, and Fitness &
Lifestyle Therapeutics among others
Market, By Application/ Solution Type:
Monitoring, Diagnosis & Treatment,
Education and Awareness, Healthcare
Management, and Wellness & Prevention
among others

Table of Contents
1 REPORT SCOPE 4.2.1.4 Healthcare providers and Pharmaceuticals
1.1 SCOPE OF THE STUDY 4.2.1.5 Patients
1.1.1 MOBILE HEALTH (MHEALTH): REPORT 4.2.1.6 Consortiums, Certification, Regulations, &
COVERAGE Standards
1.1.2 BIS RESEARCH METHODOLOGY 4.2.1.6.1 Introduction
1.1.3 RESEARCH METHODOLOGY FOR THE GLOBAL 4.2.1.6.2 Consortiums
MARKET STUDY 4.2.1.6.3 Alliance/Associations
1.1.3.1 Geographical Analysis 4.2.1.6.4 Regulatory Bodies
1.1.3.2 Demand Side & Supply Side Analysis 4.2.1.7 Food and Drug Administration (FDA)
1.1.3.3 Data Synthesis & Bridging 4.2.1.8 Medical Device Regulation Act
1.1.4 GLOBAL MOBILE HEALTH (MHEALTH): 4.2.1.9 Medical Mobile Application(MMA)
RESEARCH METHODOLOGY 4.2.2 CERTIFICATION
1.1.5 KEY DATA POINT SOURCES 4.2.3 MHEALTH DEVICE: PORTER’S FIVE FORCE
1.1.5.1 Data Points taken from Secondary Sources ANALYSIS
1.1.5.2 Data Points taken from Primary Sources 4.2.4 BARGAINING POWER OF BUYER
1.1.6 REPORT DESCRIPTION 4.2.5 BARGAINING POWER OF SUPPLIER
4.2.6 THREAT FROM SUBSTITUTE
2 EXECUTIVE SUMMARY 4.2.7 THREAT FROM A NEW ENTRANT
4.2.8 INTENSITY OF COMPETITIVE RIVALRY
3 MARKET OVERVIEW
3.1 INTRODUCTION 5 GLOBAL MHEALTH MARKET ECOSYSTEM
3.2 MARKET DYNAMICS 5.1 INTRODUCTION
3.2.1 MARKET DRIVERS 5.1.1 MHEALTH DEVICES
3.2.1.1 Patients Involvement in personal healthcare 5.1.2 MEDICAL DEVICES
3.2.1.2 Proliferation of Smartphones and wearable devices 5.1.2.1 SMBG monitor
into healthcare 5.1.2.1.1 SMBG Device Types& Uses
3.2.1.3 Integration of wireless technologies with portable 5.1.2.1.2 Diseases Managed by SMBG Device
healthcare devices
5.1.2.1.3 Key players
3.2.1.4 Introduction of connected healthcare solutions in
5.1.2.2 Blood Pressure (BP) Monitorthe mHealth market
5.1.2.2.1 BP Monitor Device Types & Uses3.2.1.5 Benefits of Cost effectiveness and Patients’
5.1.2.2.2 Diseases Managed by BP Monitor DeviceConvenience
5.1.2.2.3 Key players3.2.1.6 Increase in Lifestyle Disease
5.1.2.2.4 Pulse Oximeter3.2.2 MARKET CHALLENGES
5.1.2.2.5 Pulse Oximeter : Types & Uses3.2.2.1 Low rate of literacy and language barriers in low-
5.1.2.2.6 Diseases Managed by Pulse Oximeter Deviceand middle-income countries (LMICs)
5.1.2.2.7 Key players3.2.2.2 Invasion of Privacy
5.1.2.3 Cardiac Monitors3.2.2.2.1 Security Breach Cases
5.1.2.3.1 Diseases Managed by Cardiac Monitors3.2.2.2.2 Potential risk of Hardware or Software failure
5.1.2.3.2 Disease Management Devices Types3.2.2.2.3 Stringent Regulations and Standards
5.1.2.3.3 Cardiac Monitor Uses3.2.2.2.4 Lack of Awareness about the possible applications
of mHealth 5.1.2.4 Key players
3.2.3 MARKET OPPORTUNITIES 5.1.2.5 Other medical devices
3.2.3.1 Partnership: An entry mode 5.1.2.5.1 Health and Fitness Devices
3.2.3.2 Introduction of mHealth in developing economies 5.1.2.5.2 Hand Worn Products
5.1.2.5.2.1 Smart Watch
4 INDUSTRY DYNAMICS 5.1.2.5.2.2 Wrist Wear
4.1 MHEALTH MARKET TIMELINE 5.1.2.5.3 Key players
4.2 VALUE CHAIN OF THE MHEALTH MARKET 5.1.2.5.4 Head Worn Products
4.2.1.1 Device Manufacturers 5.1.2.5.4.1 AR/VR HMD/HUD
4.2.1.2 App Developers 5.1.2.5.4.2 Others
4.2.1.3 Network providers/ Mobile operators 5.1.2.5.4.3 Body worn products

5.1.2.5.4.4 Smart Textile 6.3.2 APPS
5.1.2.5.4.5 Wearable Patch 6.3.3 KEY PLAYERS
5.1.2.5.4.6 Others 6.4 MENTAL AND NEUROLOGICAL DISORDERS
5.1.2.5.5 Non-Clinical applications 6.4.1 DEVICES
5.1.2.5.6 Clinical Application 6.4.2 APPS
5.1.2.6 Others Devices 6.4.3 KEY PLAYERS
5.1.2.6.1 Mobile telemedicine/tele-care devices 6.5 FITNESS & LIFESTYLE THERAPEUTICS
5.1.2.6.2 Home care devices 6.5.1 DEVICES
5.1.2.6.2.1 Vessyl 6.5.2 APPS
5.1.2.6.2.2 TAO 6.5.3 KEY PLAYERS
5.1.2.6.2.3 CubeSensors 6.6 OTHERS
5.1.2.6.2.4 Kolibree
5.1.2.6.2.5 TellSpec 7 GLOBAL MHEALTHMARKET – APPLICATION/
SOLUTION TYPE5.1.2.6.2.6 Kinsa
7.1 INTRODUCTION5.1.2.6.2.7 Beddit
7.1.1 MONITORING APPLICATIONS5.1.2.6.2.8 Wello iPhone Case
7.1.1.1 Key Participants5.1.2.6.3 Key Participants
7.1.2 DIAGNOSIS & TREATMENT5.1.2.7 mHealth Services
7.1.2.1 Key Participants5.1.3 MOBILE HEALTH APPS AND CONTENT
SOLUTION 7.1.3 EDUCATION AND AWARENESS
5.1.3.1 Software 7.1.3.1 Key Participants
5.1.3.2 Big data 7.1.4 HEALTHCARE MANAGEMENT
5.1.3.3 Key Market Trends, Developments and Participants 7.1.5 WELLNESS & PREVENTION
5.1.3.3.1 Market Trends and Market Developments 7.1.6 OTHERS/ OTHER SERVICES AND
APPLICATIONS MARKET5.1.3.3.2 Key Participants
7.1.7 REMOTE DATA COLLECTION5.1.4 NETWORK AND SERVICES/ MOBILE
OPERATORS 7.1.7.1 Key Market Developments
5.1.4.1 Benefits of network & Services
5.1.4.2 Key Market Trends, Developments and Participants 8 GLOBAL MHEALTH MARKET–GEOGRAPHY
5.1.4.2.1 Market Trends and Market Developments 8.1 INTRODUCTION
5.1.4.2.2 Key Participants 8.1.1 MARKET STATISTICS
5.1.5 HEALTHCARE AND PHARMACEUTICALS 8.1.2 THE AMERICAS
5.1.5.1 Healthcare providers 8.1.3 NORTH AMERICA
5.1.5.2 Pharmaceuticals 8.1.3.1 The U.S.
5.1.5.2.1 Key Market Trends, Developments and Participants 8.1.3.1.1 Key Market trends, Developments and Participants
5.1.5.2.1.1 Market Trends and Market Developments 8.1.3.1.1.1 Key Market Trends and Developments
5.1.5.2.1.2 Key Participants 8.1.3.1.1.2 Key Participants
8.1.3.2 Canada
6 GLOBAL MHEALTH MARKET – THERAPEUTICS 8.1.3.2.1 Key Market Trend
6.1 INTRODUCTION 8.1.3.2.2 Key players
6.1.1 GLOBAL MARKET STATISTICS 8.1.3.3 South America
6.1.1.1 Cardiovascular Diseases 8.1.3.3.1 Constraints
6.1.2 DEVICES 8.1.3.3.2 Key Market Trends, Developments and Participants
6.1.3 APPS 8.1.3.3.2.1 Market Trends and Market Developments
6.1.4 KEY PLAYERS 8.1.3.3.2.2 Key Participants
6.2 DIABETES 8.1.4 ASIA-PACIFIC (APAC)
6.2.1 DEVICES 8.1.4.1 Key Drivers in APAC
6.2.2 APPS 8.1.4.1.1 Key Market Trends, Developments and Participants
6.2.3 KEY PLAYERS 8.1.4.1.1.1 Market Trends & Development
6.3 RESPIRATORY 8.1.4.1.1.2 Key Participants
6.3.1 DEVICES 8.1.4.2 CHINA

8.1.4.3 JAPAN 10.4.2.3 Financial Summary
8.1.4.4 AUSTRALIA 10.4.3 KEY DEVELOPMENT
8.1.4.5 INDIA 10.5 AT&T, INC.
8.1.5 EUROPE 10.5.1 OVERVIEW
8.1.5.1 Key Market Trends, Developments and Participants 10.5.2 FINANCIALS
8.1.5.2 The U.K. 10.5.2.1 Overall Financials
8.1.5.3 Germany 10.5.2.2 Financials By Segment
8.1.5.4 Key Participants 10.5.2.3 Financial Summary
8.1.6 REST OF THE WORLD (ROW) 10.5.3 KEY DEVELOPMENTS
8.1.6.1 Africa 10.6 BIOTELEMETRY, INC. (CARDIONET)
8.1.6.1.1 Key Market Trends, Developments and Participants 10.6.1 OVERVIEW
8.1.6.1.1.1 Market Trends and Market Developments 10.6.2 FINANCIALS
8.1.6.1.2 Key Participants 10.6.2.1 Overall Financials
8.1.7 MIDDLE EAST 10.6.2.2 Financials by Segment
8.1.7.1 Key Market Trends, Developments and Participants 10.6.2.3 Financial Summary
8.1.7.1.1 Market Trends and Market Developments 10.6.3 KEY DEVELOPMENTS
8.1.7.1.2 Key Participants 10.7 GE HEALTHCARE
10.7.1 OVERVIEW
9 KEY MARKET DEVELOPMENT AND 10.7.2 FINANCIALS
STRATEGIES 10.7.2.1 Overall Financials
9.1 INTRODUCTION 10.7.2.2 Financials by Segment
9.1.1 PARTNERSHIPS, AGREEMENTS, AND 10.7.2.3 Financial Summary
COLLABORATIONS 10.7.3 KEY DEVELOPMENTS
9.1.2 MERGERS & ACQUISITIONS 10.8 GOOGLE INC.
9.1.3 PRODUCT DEVELOPMENT AND LAUNCH 10.8.1 OVERVIEW
9.1.4 BUSINESS EXPANSION/CONTRACTS 10.8.2 FINANCIALS
9.1.5 PATENTS, APPROVALS AND CERTIFICATIONS 10.8.2.1 Financial Summary
9.1.6 OTHERS (EVENTS & RECOGNITIONS) 10.8.3 KEY DEVELOPMENTS
10.9 JAWBONE, INC.
10 COMPANY PROFILES 10.9.1 OVERVIEW
10.1 AGAMATRIX, INC. 10.9.2 FINANCIALS
10.1.1 OVERVIEW 10.9.3 KEY DEVELOPMENTS
10.1.2 FINANCIALS 10.10 JOHNSON & JOHNSON
10.1.3 KEY DEVELOPMENTS 10.10.1 OVERVIEW
10.2 ALIVECOR, INC. 10.10.2 FINANCIALS
10.2.1 OVERVIEW 10.10.2.1 Overall Financials
10.2.2 FINANCIALS 10.10.2.2 Net Revenue By Segment
10.2.3 KEY DEVELOPMENTS 10.10.2.3 Net revenue by Region
10.3 APPLE, INC. 10.10.3 KEY DEVELOPMENTS
10.3.1 OVERVIEW 10.11 LABORATORY CORPORATION OF AMERICA
10.3.2 FINANCIALS HOLDINGS
10.3.2.1 Overall Financials 10.11.1 OVERVIEW
10.3.2.2 Financials By Segment 10.11.2 FINANCIALS
10.3.2.3 Financials By Region 10.11.2.1 Overall Financials
10.3.2.4 Financial Summary 10.11.2.2 Financials by Segment
10.3.3 KEY DEVELOPMENT 10.11.2.3 Financial Summary
10.4 ATHENAHEALTH INC. 10.11.3 KEY DEVELOPMENTS
10.4.1 OVERVIEW 10.12 MEDTRONIC PLC
10.4.2 FINANCIALS 10.12.1 OVERVIEW
10.4.2.1 Overall Financials 10.12.2 FINANCIALS
10.4.2.2 Financial by Segments 10.12.2.1 Overall Financials

10.12.2.2 Financial Summary 10.17 QUEST DIAGNOSTICS INC.
10.13 NIKE INC. 10.17.2 FINANCIALS
10.13.2 FINANCIALS 10.17.2.2 Financials by Segment
10.13.2.1 Overall Financials 10.17.2.3 Financial Summary
10.13.2.2 Financials by Segments 10.17.3 KEY DEVELOPMENTS
10.13.2.3 Financial Summary 10.18 ROCHE HOLDING AG-BR
10.14 PFIZER 10.18.2 FINANCIALS
10.14.2 FINANCIALS 10.18.2.2 Financials by Segment
10.14.2.1 Overall Financials 10.18.2.3 Financial Summary
10.14.2.2 Financials by Segment 10.18.3 KEY DEVELOPMENTS
10.14.2.3 Financials By Region 10.19 SAMSUNG ELECTRONICS CO. LTD.
10.14.2.4 FINANCIAL SUMMARY 10.19.1 OVERVIEW
10.14.3 KEY DEVELOPMENTS 10.19.2 FINANCIALS
10.15 PHILIPS HEALTHCARE 10.19.2.1 Overall financials
10.15.1 OVERVIEW 10.19.2.2 Financial Summary
10.15.2 FINANCIALS 10.19.3 KEY DEVELOPMENTS
10.15.2.1 Overall Financials 10.20 SANOFI PHARMA
10.15.2.2 Financials By Region 10.20.1 OVERVIEW
10.15.2.4 Financial Summary 10.20.2.1 Overall Financials
10.15.3 KEY DEVELOPMENTS 10.20.3 FINANCIALS BY SEGMENT
10.16 QUALCOMM, INC. 10.20.4 FINANCIAL SUMMARY
10.16.1 OVERVIEW 10.20.5 KEY DEVELOPMENTS
10.16.2 FINANCIALS 10.21 WITHINGS SAS
10.16.2.1 Overall Financials 10.21.1 OVERVIEW
10.16.2.3 Financials By Region 10.21.3 KEY DEVELOPMENTS
10.16.2.4 Financial Summary
10.16.3 KEY DEVELOPMENTS
TABLE 1 LEADING COMPANIES IN THE MHEALTH MARKET
TABLE 2 SECURITY BREACHMENT CASES/ DEVELOPMENTS (2011-2015)
TABLE 3 MHEALTH INDUSTRY: KEY PARTNERSHIPS
TABLE 4 VALUE CHAIN: KEY PARTICIPANTS OFECOSYSTEM
TABLE 5 CONSORTIUMS IN MHEALTH MARKET
TABLE 6 ALLIANCE/ASSOCIATIONS IN MHEALTH MARKET
TABLE 7 REGULATORY BODIES IN MHEALTH MARKET
TABLE 8 MHEALTH MARKET CERTIFICATIONS
TABLE 9 FACTORS IMPACTING THE BUYER’S BARGAINING POWER
TABLE 10 FACTORS IMPACTING THE SUPPLIER’S BARGAINING POWER
TABLE 11 FACTORS IMPACTING THE THREAT FROM SUBSTITUTE
TABLE 12 FACTORS IMPACTING THE THREAT FROM NEW ENTRANT
TABLE 13 FACTORS IMPACTING THE DEGREE OF COMPETETION
TABLE 14 GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022 ($MILLION)
List of Tables

TABLE 15 GLOBAL MHEALTH DEVICE MARKET VALUE, BY DEVICE TYPE, 2014-2022 ($MILLION)
TABLE 16 GLOBAL MHEALTH DEVICE MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
TABLE 17 GLOBAL MHEALTH SERVICE MARKET VALUE, BY SERVICE TYPE, 2014-2022 ($MILLION)
TABLE 18 GLOBAL MHEALTHSERVICES MARKET VALUE, BY APPLICATION TYPE 2014-2022 ($MILLION)
TABLE 19 KEY DEVELOPMENTS
TABLE 20 NETWORK & SERVICES: KEY DEVELOPMENTS
TABLE 21 PHARMACEUTICALS SERVICE: KEY DEVELOPMENT
TABLE 22 GLOBAL MHEALTHMARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 23 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022
($MILLION)
TABLE 24 CARDIOVASCULAR DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 25 TYPE OF APP
TABLE 27 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 28 DIABETES: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 30 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 31 RESPIRATORY DISEASE: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 32 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022
($MILLION)
TABLE 33 NEUROLOGY/ MENTAL HEALTH: GLOBAL MHEALTHMARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 34 FITNESS & LIFESTYLE: GLOBAL MHEALTHMARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 35 FITNESS & LIFESTYLE: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 36 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 37 OTHER DISEASES: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 38 GLOBAL MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 39 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION)
TABLE 40 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION)
TABLE 41 MONITORING APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 42 REMOTE MONITORING IN GEOGRAPHIES
TABLE 43 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION)
TABLE 44 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION)
TABLE 45 DIAGNOSIS & TREATMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 46 DIAGNOSIS AND TREATMENT IN GEOGRAPHIES
TABLE 47 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION)
TABLE 48 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION)
TABLE 49 EDUCATION & AWARENESSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)

TABLE 50 EDUCATION & WELLNESS IN GEOGRAPHIES
TABLE 51 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION)
TABLE 52 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION)
TABLE 53 HEALTHCARE MANAGEMENTS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 54 HEALTHCARE MANAGEMENT IN GEOGRAPHIES
TABLE 55 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION)
TABLE 56 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION)
TABLE 57 WELLNESS & PREVENTIONS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 58 WELLNESS & PREVENTION APPLLICATIONS IN DIFFERENT GEOGRAPHIES
TABLE 59 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY ECOSYSTEM, 2014-2022
($MILLION)
TABLE 60 OTHERS APPLICATIONS: GLOBAL MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022
($MILLION)
TABLE 61 OTHERS APPLICATIONSS: GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022
($MILLION)
TABLE 62 MHEALTH: KEY DEVELOPMENTS (2011- 2015)
TABLE 63 GLOBAL MHEALTH MARKET VALUE, BY GEOGRAPHY, 2014-2022 ($MILLION)
TABLE 64 THE AMERICAS: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)
TABLE 65 THE AMERICAS: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 66 THE AMERICAS: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 67 THE U.S.: KEY DEVELOPMENTS
TABLE 68 SOUTH AMERICA: MHEALTH MARKET DEVELOPMENT (2011-2015)
TABLE 69 APAC: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 70 APAC: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 71 KEY DEVELOPMENTS IN APAC
TABLE 72 EUROPE: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 73 EUROPE: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 74 EUROPE: MHEALTH MARKET DEVELOPMENT
TABLE 75 ROW: MHEALTH MARKET VALUE, BY REGIONS, 2014-2022 ($MILLION)
TABLE 76 ROW: MHEALTH MARKET VALUE, BY THERAPEUTICS, 2014-2022 ($MILLION)
TABLE 77 ROW: MHEALTH MARKET VALUE, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 78 AFRICA: MHEALTH MARKET DEVELOPMENTS(2011-2014)
TABLE 79 MIDDLE EAST: MHEALTH MARKET DEVELOPMENTS (2014-2011)

FIGURE 1 MHEALTH MARKET STUDY: COVERAGE AREA
FIGURE 2 BIS RESEARCH METHODOLOGY
FIGURE 3 DIFFERENT PHASES OF RESEARCH METHODOLOGY FOR THE GLOBAL MARKET
FIGURE 4 MHEALTH MARKET: RESEARCH METHODOLOGY
FIGURE 5 GLOBAL MHEALTH MARKET, BY ECOSYSTEM, 2014-2022 ($MILLION)
FIGURE 6 GLOBAL MHEALTH MARKET, BY THERAPEUTICS, 2014-2022 ($MILLION)
FIGURE 7 GLOBAL MHEALTH MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 8 GLOBAL MHEALTH MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
FIGURE 9 MARKET DRIVERS AND CHALLENGES
FIGURE 10 MHEALTH MARKET DRIVERS: IMPACT ANALYSIS
FIGURE 11 BENEFITS OF MHEALTH TO PATIENTS
FIGURE 12 EXAMPLES OF EXISTING MHEALTH INNOVATIONS
FIGURE 13 MHEALTH MARKET CHALLENGES: IMPACT ANALYSIS
FIGURE 14 MAJOR BARRIERS CAUSED BY REGULATION AND STANDARDS
FIGURE 15 VALUE CHAIN
FIGURE 16 ROLES AND RESPONSIBILITIES OF HEALTHCARE POLICY MAKERS
FIGURE 17 CLASSIFICATION OF MEDICAL DEVICES
FIGURE 18 MHEALTH MARKET: PORTER FIVE FORCE ANALYSIS
FIGURE 19 MHEALTH ECOSYSTEM
FIGURE 20 TYPE OF MHEALTH DEVICES
FIGURE 21 SMBD DEVICE USES
FIGURE 22 USES OF BP MONITORING DEVICE
FIGURE 23 PULSE OXIMETER USES
FIGURE 24 WEARABLE DEVICE COMPONENTS
FIGURE 25 TYPE OF WEARABLE ELECTRONICS DEVICES
FIGURE 26 HAND WORN MHEALTH DEVICES
FIGURE 27 APPLE WATCH FIGURE
FIGURE 28 LEADING FITNESS TRACKING WRIST BANDS
FIGURE 29 GOOGLE’S CONTACT LENS
FIGURE 30 HEAD WORN DEVICES
FIGURE 31 ELECTRONIC FINGERTIP
FIGURE 32 COMPONENTS OF BIOSTAMP
FIGURE 33 MYO ARMBAND BY THALMIC LABS
FIGURE 34 NON-CLINICAL BENEFITS
FIGURE 35 WEARABLE MEDICAL DEVICES
FIGURE 36 FITNESS TRACKING DEVICES
FIGURE 37 TYPES OF MHEALTH SERVICES
FIGURE 38 TYPES OF APPS
FIGURE 39 BENEFITS OF BIG DATA
FIGURE 40 BENEFITS OF NETWORK & SERVICES
FIGURE 41 ROLES OF MOBILE OPERATORS
FIGURE 42 ROLE OF HEALTHCARE PROVIDERS
FIGURE 43 MHEALTH: MARKET BY THERAPEUTICS
FIGURE 44 BENEFITS OF MHEALTH IN CVDS
FIGURE 45 BENEFITS OF MHEALTH
List of Figures

FIGURE 49 TYPES OF MHEALTH APPLICATION
FIGURE 50 ADVANTAGES OF REMOTE MONITORING
FIGURE 51 DIAGNOSIS AND TREATMENT SERVICES
FIGURE 52 EDUCATION & AWARENESS SERVICES
FIGURE 53 MHEALTH HEALTHCARE MANAGEMENT
FIGURE 54 GLOBAL MHEALTH MARKET CLASSIFICATION, BY GEOGRAPHY
FIGURE 55 APAC: MARKET DRIVERS
FIGURE 56 MHEALTH: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2015)
FIGURE 57 MHEALTH: MERGERS & ACQUISITIONS(2015)
FIGURE 58 MHEALTH: KEY PRODUCT LAUNCH & DEVELOPMENTS (2015)
FIGURE 59 MHEALTH: KEY BUSINESS EXPANSIONS & CONTRACTS (2015)
FIGURE 60 MHEALTH: KEY PATENTS/APPROVALS( 2015)
FIGURE 61 APPLE INC. OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 62 APPLE INC.: NET REVENUE, BY SEGMENT, 2012-2014
FIGURE 63 APPLE INC.: NET REVENUE, BY REGION, 2012-2014
FIGURE 64 ATHENAHEALTH: OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 65 ATHENAHEALTH: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 66 AT&T INC.: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 67 AT&T INC.: NET REVENUE BY SEGMENT, 2012-2014
FIGURE 68 BIOTELEMETRY INC.: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 69 BIOTELEMETRY INC.: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014
FIGURE 70 GE CORPORATION: OVERALL FINANCIALS ($MILLION), 2012-2014
FIGURE 71 GE ELECTRONIC: NET REVENUE BY SEGMENTS ($MILLION), 2012-2014
FIGURE 72 GE HEALTHCARE SEGMENT, 2014
FIGURE 73 GOOGLE: OVERALL FINANCIALS, 2012 - 2014 ($BILLION)
FIGURE 74 J&J: OVERALL FINANCIALS, 2012 - 2014 ($ BILLION)
FIGURE 75 LABCORP OVERALL FINANCIALS ($MILLION), 2012-2014
FIGURE 76 NET REVENUE BY SEGMENTS, 2012-2014
FIGURE 77 NIKE: OVERALL FINANCIALS 2012 - 2014 ($BILLION)
FIGURE 78 NIKE: REVENUE BY REGION (2012-2013)
FIGURE 79 PFIZER: OVERALL FINANCIALS, 2012-2014 ($BILLION)
FIGURE 80 PFIZER: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 81 PFIZER: FINANCIALS BY REGION, 2012-2013 ($BILLION)
FIGURE 82 PHILIPS: OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 83 PHILIPS: FINANCIALS BY REGION, 2012-2014 ($MILLION)
FIGURE 84 PHILIPS: FINANCIALS BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 85 QUALCOMM INC.: OVERALL FINANCIALS, 2012-2014 ($BILLION)
FIGURE 86 QUALCOMM INC.: NET REVENUE, BY SEGMENT, 2012-2014 ($MILLION)
FIGURE 87 QUALCOMM INC.: NET REVENUE, BY REGION, 2012-2014 ($MILLION)
FIGURE 88 QUEST: OVERALL FINANCIALS, 2012-2014 ($MILLION)
FIGURE 89 QUEST: NET REVENUE BY SEGMENTS, 2013-2014 ($MILLION)
FIGURE 90 ROCHE: OVERALL FINANCIALS, 2012-2014 ($BILLION)
FIGURE 91 ROCHE: NET REVENUE, BY SEGMENTS, 2012-2014 ($BILLION)

FIGURE 92 SAMSUNG ELECTRONICS CO. LTD.: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 93 SANOFI PHARMA: OVERALL FINANCIALS ($BILLION), 2012-2014
FIGURE 94 SANOFI PHARMA: NET REVENUE BY SEGMENT, 2012-2014
About BIS (www.bisresearch.com)
BIS Research provides valuable market intelligence to an exclusive group of customers in response to orders. The report is licensed for
the customer's internal use only and is subject to restrictions set henceforth. This document and its contents are confidential and may not
be further distributed, published or reproduced, in whole or in part, by any medium or in any form for any purpose, without the express
written consent of BIS Research. Customer will not disclose the contents of the report, whether directly in any media or indirectly through
incorporation in a database, marketing list, report or otherwise, or use or permit the use of Information to generate any statistical or other
information that is or will be provided to third parties; or voluntarily produce Information in legal proceedings.
Market reports are based on expectations, estimates and projections as of the date such information is available. Any recommendation
contained in this report may not be suitable for all investors or businesses. The market conclusions drawn are necessarily based upon a
number of estimates and assumptions that, while considered reasonable by BIS Research as of the date of such statements, are
inherently subject to market fluctuations and business, economic and competitive uncertainties and contingencies
BIS Research
9100 West Bloomington Freeway,
Suite 159 Bloomington,
MN 55431
E-mail : sales@bisresearch.com
Call Us : +1-650-228-0182
Global Delivery Center
A-21, Kailash Colony,
New Delhi,
India
Tel : +91 11 46120391
For more details regarding permission, please contact us:

Global M-Health(mobile health) Market | BIS Research

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (16)

Recently uploaded

Recently uploaded (20)

Global M-Health(mobile health) Market | BIS Research